{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:19:33Z","timestamp":1787235573933,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clml.2024.12.007","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T01:46:27Z","timestamp":1734831987000},"page":"e232-e242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Efficacy and Safety of Total Body Irradiation Versus Chemotherapy Conditioning for Hematopoietic Stem Cell Transplant in Adult Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"Hasaan","family":"Ans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqah","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Sajjad","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tazeen","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Yar","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Usama","family":"Imtiaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasih Mand","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8118-4849","authenticated-orcid":false,"given":"Mohammad Ebad Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Salman","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9617","key":"10.1016\/j.clml.2024.12.007_bib0001","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet Lond Engl"},{"issue":"10230","key":"10.1016\/j.clml.2024.12.007_bib0002","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet Lond Engl"},{"issue":"15","key":"10.1016\/j.clml.2024.12.007_bib0003","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/cncr.29383","article-title":"New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia","volume":"121","author":"Jabbour","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clml.2024.12.007_bib0004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02988834","article-title":"Bone marrow transplantation for acute lymphoblastic leukemia (ALL)","volume":"11","author":"Lazarus","year":"1994","journal-title":"Med Oncol Northwood Lond Engl"},{"issue":"3","key":"10.1016\/j.clml.2024.12.007_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/17474086.2018.1433030","article-title":"Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state","volume":"11","author":"Saadeh","year":"2018","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"10.1016\/j.clml.2024.12.007_bib0006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clml.2023.01.004","article-title":"Total body irradiation versus chemotherapy conditioning in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplant: a systematic review and meta-analysis","volume":"23","author":"Rehman","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"10.1016\/j.clml.2024.12.007_bib0007","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/curroncol28010089","article-title":"Total body irradiation for hematopoietic stem cell transplantation: what can we agree on?","volume":"28","author":"Sabloff","year":"2021","journal-title":"Curr Oncol Tor Ont"},{"key":"10.1016\/j.clml.2024.12.007_bib0008","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","year":"2024"},{"key":"10.1016\/j.clml.2024.12.007_bib0009","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2024.12.007_bib0010","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2024.12.007_bib0011","unstructured":"Ottawa Hospital Research Institute. Accessed July 5, 2024. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"3","key":"10.1016\/j.clml.2024.12.007_bib0012","first-page":"4","article-title":"Total body irradiation-based conditioning versus chemotherapy before allogeneic stem cell transplantation for adults with acute lymphoblastic leukemia","volume":"6","author":"Abdeljelil","year":"2024","journal-title":"Clin Hematol Int"},{"issue":"3","key":"10.1016\/j.clml.2024.12.007_bib0013","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41409-019-0702-2","article-title":"Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party","volume":"55","author":"Bazarbachi","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.clml.2024.12.007_bib0014","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/bmt.2015.278","article-title":"Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT","volume":"51","author":"Cahu","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.clml.2024.12.007_bib0015","doi-asserted-by":"crossref","first-page":"171.e1","DOI":"10.1016\/j.jtct.2020.10.008","article-title":"Improved outcomes of haploidentical hematopoietic cell transplantation with total body irradiation-based myeloablative conditioning in acute lymphoblastic leukemia","volume":"27","author":"Dholaria","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.clml.2024.12.007_bib0016","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3109\/10428194.2013.779691","article-title":"Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant","volume":"54","author":"Eroglu","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.clml.2024.12.007_bib0017","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41409-020-01101-z","article-title":"Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia","volume":"56","author":"Greil","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"14","key":"10.1016\/j.clml.2024.12.007_bib0018","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1080\/10428194.2019.1636986","article-title":"The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation","volume":"60","author":"Harada","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.clml.2024.12.007_bib0019","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41409-023-01966-w","article-title":"Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years\u2014A registry-based study by the Acute Leukemia Working Party of the EBMT","volume":"58","author":"Hirschb\u00fchl","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.clml.2024.12.007_bib0020","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/bmt.2010.314","article-title":"BU- vs TBI-based conditioning for adult patients with ALL","volume":"46","author":"Kalaycio","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.clml.2024.12.007_bib0021","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbmt.2017.11.025","article-title":"Intravenous busulfan compared with total body irradiation pretransplant conditioning for adults with acute lymphoblastic leukemia","volume":"24","author":"Kebriaei","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.clml.2024.12.007_bib0022","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/10428194.2021.2018583","article-title":"Total body irradiation-based versus busulfan-based myeloablative conditioning for single-unit cord blood transplantation in adults","volume":"63","author":"Konuma","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.clml.2024.12.007_bib0023","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41409-024-02298-z","article-title":"Total body irradiation versus thiotepa\/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia","volume":"59","author":"Mora","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.clml.2024.12.007_bib0024","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.bbmt.2016.09.007","article-title":"Comparison of cyclophosphamide combined with total body irradiation, oral busulfan, or intravenous busulfan for allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia","volume":"22","author":"Mitsuhashi","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clml.2024.12.007_bib0025","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/09636897221108890","article-title":"Total body irradiation\u2013based conditioning regimen improved the survival of adult patients with T-cell lymphoblastic lymphoma after allogeneic peripheral blood stem cell transplantation","volume":"31","author":"Niu","year":"2022","journal-title":"Cell Transplant"},{"key":"10.1016\/j.clml.2024.12.007_bib0026","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-019-0790-x","article-title":"Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT","volume":"12","author":"Pavl\u016f","year":"2019","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"11","key":"10.1016\/j.clml.2024.12.007_bib0027","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.1016\/j.clml.2019.08.005","article-title":"Comparison of different conditioning regimens in allogeneic hematopoietic stem-cell transplantation shows superiority of total body irradiation-based regimen for younger patients with acute leukemia: a nationwide study","volume":"19","author":"Park","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"10.1016\/j.clml.2024.12.007_bib0028","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00277-018-3383-9","article-title":"Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study","volume":"97","author":"Sakellari","year":"2018","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.clml.2024.12.007_bib0029","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/s41409-024-02280-9","article-title":"Busulfan plus cyclophosphamide vs. total body irradiation plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in patients with acute T lymphoblastic leukemia: a large-scale propensity score matching-based study","volume":"59","author":"Shen","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.clml.2024.12.007_bib0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41409-021-01550-0","volume":"57","author":"Swoboda","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.clml.2024.12.007_bib0031","first-page":"e1488","article-title":"Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: a Taiwan observational study","volume":"5","author":"Wang","year":"2021","journal-title":"Cancer Rep"},{"issue":"2","key":"10.1016\/j.clml.2024.12.007_bib0032","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/JCO.22.00767","article-title":"Busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for adults acute B lymphoblastic leukemia: an open-label, multicenter, phase III trial","volume":"41","author":"Zhang","year":"2023","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clml.2024.12.007_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.03.026","article-title":"Impact of total body irradiation-based myeloablative conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: systematic review and meta-analysis","volume":"27","author":"Khimani","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.clml.2024.12.007_bib0034","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3109\/10428194.2013.779691","article-title":"Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant","volume":"54","author":"Eroglu","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.clml.2024.12.007_bib0035","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","article-title":"Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993","volume":"106","author":"Rowe","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.clml.2024.12.007_bib0036","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.bbmt.2018.03.011","article-title":"A comparison of the myeloablative conditioning regimen fludarabine\/busulfan with cyclophosphamide\/total body irradiation, for allogeneic stem cell transplantation in the modern era: a cohort analysis","volume":"24","author":"Gooptu","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.clml.2024.12.007_bib0037","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41409-024-02298-z","article-title":"Total body irradiation versus thiotepa\/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia","volume":"59","author":"Mora","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.clml.2024.12.007_bib0038","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijrobp.2018.04.071","article-title":"Total Body Irradiation: guidelines from the International Lymphoma Radiation Oncology Group (ILROG)","volume":"101","author":"Wong","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clml.2024.12.007_bib0039","series-title":"Basics of Hematopoietic Stem Cell Transplant","first-page":"231","article-title":"Total Body Irradiation","author":"Sharma","year":"2023"},{"issue":"1","key":"10.1016\/j.clml.2024.12.007_bib0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0360-3016(00)01373-0","article-title":"Long-term complications of total body irradiation in adults","volume":"49","author":"Thomas","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024024467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024024467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:39:25Z","timestamp":1772606365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024024467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2152265024024467"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.12.007","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.16.24316211","asserted-by":"object"}]},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Total Body Irradiation Versus Chemotherapy Conditioning for Hematopoietic Stem Cell Transplant in Adult Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}